Lifestyle changes and mazdutide injection for weight loss
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests whether combining lifestyle changes (diet and exercise) with a medication called mazdutide can help adults with obesity lose weight and keep it off. Mazdutide is an injectable medication that may help reduce appetite and support weight management over 2 years.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- Your BMI (body mass index, a measure of weight relative to height) is between 28.0 and 45.0
- You do not have diabetes or take diabetes medications
- You have not had major heart problems, stroke, or chest pain in the past 6 months
- You are not a current smoker and have not smoked regularly in the past 3 months
- You can commit to follow-up visits over 2 years
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an experimental drug (LY3437943) can help people with obesity or overweight lose weight. It compares the drug to a placebo (inactive shot), and you must be willing to give yourself daily injections.
This trial tests a once-weekly injection (tirzepatide) versus a placebo to help people who are obese or overweight with related health conditions lose weight. You may qualify if you have tried to lose weight through diet before, but have not been successful.
This study tests an experimental injection called HDM1005 for adults with obesity who do not have diabetes. The goal is to see if it helps with weight loss when combined with diet and exercise.
This trial tests combining a weight-loss medication (mazdutide) with a hormone-releasing intrauterine device (LNG-IUS) to treat early-stage uterine cancer or precancerous changes while preserving fertility. It aims to help patients who are overweight or obese and wish to avoid hysterectomy.
This study tests a new medicine called Zenagamtide to help people with excess body weight lose weight. It is designed for adults in Asia who do not have diabetes.
This study tests a once-weekly injection called mazdutide to help adults with prediabetes and higher weight lower their blood sugar and potentially lose weight. It is a double-blind, placebo-controlled trial, meaning some people get the real drug and some get a placebo (no active drug).
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.